Cost effectiveness of retreatment with consensus interferon for chronic hepatitis C.

被引:0
|
作者
McHutchison, JG
Woolley, JM
Nyberg, LM
机构
[1] SCRIPPS CLIN,LA JOLLA,CA 92037
[2] AMGEN INC,THOUSAND OAKS,CA 91320
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1171 / 1171
页数:1
相关论文
共 50 条
  • [21] Chronic hepatitis C: Retreatment of pegylated interferon/ribavirin nonresponders
    Cardoso, Helder
    Vale, Ana Horta
    Mendes, Margarida
    Bastos, Pedro
    Machado, Artur
    Santos, Carlos
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S192 - S193
  • [22] Retreatment of chronic hepatitis C with ribavirin followed by alpha interferon
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Silini, E
    Vicari, F
    Asti, L
    Zavaglia, C
    Ideo, G
    HEPATOLOGY RESEARCH, 1997, 7 (02) : 121 - 129
  • [23] RETREATMENT OF CHRONIC HEPATITIS-C WITH INTERFERON-ALPHA
    MARRIOTT, E
    QUIROGA, JA
    CARRENO, V
    JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (05): : 1200 - 1201
  • [24] Estimating the cost-effectiveness of ribavirin and pegylated interferon alfa-2B for chronic hepatitis C.
    Wong, JB
    HEPATOLOGY, 2000, 32 (04) : 425A - 425A
  • [25] Cost-effectiveness of liver biopsy in patients with chronic hepatitis C.
    Forns, X
    Ampurdanes, S
    Bruguera, M
    Sanchez-Tapias, JM
    Rodes, J
    HEPATOLOGY, 2000, 32 (04) : 547A - 547A
  • [26] Cost-effectiveness of combination therapy for relapsers with chronic hepatitis C.
    Buti, M
    Casado, MA
    Fosbrook, L
    Esteban, R
    HEPATOLOGY, 1999, 30 (04) : 197A - 197A
  • [27] Cost-effectiveness study of treatment in patients with chronic hepatitis C.
    Joliot, E
    Vanlemmens, C
    Kerleau, M
    LeGales, C
    WoronoffLemsi, MC
    Flori, YA
    Seror, V
    Hrusovsky, S
    Monnet, E
    BressonHadni, S
    Miguet, JP
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1996, 20 (11): : 958 - 967
  • [28] Efficacy of interferon retreatment on interferon-resistant patients with chronic hepatitis C
    Egusa, K
    Kondo, J
    ACTA MEDICA OKAYAMA, 2003, 57 (03) : 151 - 158
  • [29] Acute onset of nephrotic syndrome during interferon-alfa retreatment for chronic active hepatitis C.
    Nishimura, S
    Miura, H
    Yamada, H
    Kitamura, S
    Shinoda, T
    HEPATOLOGY, 2001, 34 (04) : 592A - 592A
  • [30] Two year interferon retreatment may induce a sustained response in relapsing patients with chronic hepatitis C.
    Picciotto, A
    Brizzolara, R
    Campo, N
    Poggi, G
    Sinelli, N
    DeConca, V
    GiudiciCipriani, A
    Grasso, A
    Marenco, G
    Menardo, G
    Dodero, M
    Celle, G
    HEPATOLOGY, 1996, 24 (04) : 585 - 585